Anna Neufeld, Lucy L Gao, Joshua Popp, Alexis Battle, Daniela Witten
{"title":"单细胞 RNA 测序数据的潜变量估计后推断。","authors":"Anna Neufeld, Lucy L Gao, Joshua Popp, Alexis Battle, Daniela Witten","doi":"10.1093/biostatistics/kxac047","DOIUrl":null,"url":null,"abstract":"<p><p>In the analysis of single-cell RNA sequencing data, researchers often characterize the variation between cells by estimating a latent variable, such as cell type or pseudotime, representing some aspect of the cell's state. They then test each gene for association with the estimated latent variable. If the same data are used for both of these steps, then standard methods for computing p-values in the second step will fail to achieve statistical guarantees such as Type 1 error control. Furthermore, approaches such as sample splitting that can be applied to solve similar problems in other settings are not applicable in this context. In this article, we introduce count splitting, a flexible framework that allows us to carry out valid inference in this setting, for virtually any latent variable estimation technique and inference approach, under a Poisson assumption. We demonstrate the Type 1 error control and power of count splitting in a simulation study and apply count splitting to a data set of pluripotent stem cells differentiating to cardiomyocytes.</p>","PeriodicalId":55357,"journal":{"name":"Biostatistics","volume":" ","pages":"270-287"},"PeriodicalIF":1.8000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Inference after latent variable estimation for single-cell RNA sequencing data.\",\"authors\":\"Anna Neufeld, Lucy L Gao, Joshua Popp, Alexis Battle, Daniela Witten\",\"doi\":\"10.1093/biostatistics/kxac047\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In the analysis of single-cell RNA sequencing data, researchers often characterize the variation between cells by estimating a latent variable, such as cell type or pseudotime, representing some aspect of the cell's state. They then test each gene for association with the estimated latent variable. If the same data are used for both of these steps, then standard methods for computing p-values in the second step will fail to achieve statistical guarantees such as Type 1 error control. Furthermore, approaches such as sample splitting that can be applied to solve similar problems in other settings are not applicable in this context. In this article, we introduce count splitting, a flexible framework that allows us to carry out valid inference in this setting, for virtually any latent variable estimation technique and inference approach, under a Poisson assumption. We demonstrate the Type 1 error control and power of count splitting in a simulation study and apply count splitting to a data set of pluripotent stem cells differentiating to cardiomyocytes.</p>\",\"PeriodicalId\":55357,\"journal\":{\"name\":\"Biostatistics\",\"volume\":\" \",\"pages\":\"270-287\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2023-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biostatistics\",\"FirstCategoryId\":\"100\",\"ListUrlMain\":\"https://doi.org/10.1093/biostatistics/kxac047\",\"RegionNum\":3,\"RegionCategory\":\"数学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MATHEMATICAL & COMPUTATIONAL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biostatistics","FirstCategoryId":"100","ListUrlMain":"https://doi.org/10.1093/biostatistics/kxac047","RegionNum":3,"RegionCategory":"数学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MATHEMATICAL & COMPUTATIONAL BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
在分析单细胞 RNA 测序数据时,研究人员通常会通过估计一个代表细胞状态某些方面的潜变量(如细胞类型或伪时间)来描述细胞之间的变化。然后,他们测试每个基因是否与估计的潜变量相关。如果在这两个步骤中使用相同的数据,那么在第二步中计算 p 值的标准方法将无法实现统计保证,如类型 1 错误控制。此外,在其他情况下可用于解决类似问题的方法,如样本拆分,在此情况下也不适用。在本文中,我们介绍了计数分割,这是一个灵活的框架,允许我们在泊松假设下,针对几乎所有的潜变量估计技术和推断方法,在这种情况下进行有效的推断。我们在模拟研究中演示了计数分割的第一类错误控制和威力,并将计数分割应用于多能干细胞分化为心肌细胞的数据集。
Inference after latent variable estimation for single-cell RNA sequencing data.
In the analysis of single-cell RNA sequencing data, researchers often characterize the variation between cells by estimating a latent variable, such as cell type or pseudotime, representing some aspect of the cell's state. They then test each gene for association with the estimated latent variable. If the same data are used for both of these steps, then standard methods for computing p-values in the second step will fail to achieve statistical guarantees such as Type 1 error control. Furthermore, approaches such as sample splitting that can be applied to solve similar problems in other settings are not applicable in this context. In this article, we introduce count splitting, a flexible framework that allows us to carry out valid inference in this setting, for virtually any latent variable estimation technique and inference approach, under a Poisson assumption. We demonstrate the Type 1 error control and power of count splitting in a simulation study and apply count splitting to a data set of pluripotent stem cells differentiating to cardiomyocytes.
期刊介绍:
Among the important scientific developments of the 20th century is the explosive growth in statistical reasoning and methods for application to studies of human health. Examples include developments in likelihood methods for inference, epidemiologic statistics, clinical trials, survival analysis, and statistical genetics. Substantive problems in public health and biomedical research have fueled the development of statistical methods, which in turn have improved our ability to draw valid inferences from data. The objective of Biostatistics is to advance statistical science and its application to problems of human health and disease, with the ultimate goal of advancing the public''s health.